Trial NCT01329549

View at ClinicalTrials.gov 
Org. Study IDs: 1199.117

Last trial update was posted on 2014-11-27

MeSH Interventions

Carboplatin Nintedanib

MeSH Conditions

Ovarian Neoplasms

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

The trial was prematurely terminated because of worldwide disruption of pegylated liposomal doxorubicin (PLD) supplies.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID